EP Patent

EP2081929B1 — Substituted 3-isobutyl-9, 10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto

Assigned to Neurocrine Biosciences Inc · Expires 2013-01-09 · 13y expired

What this patent protects

Patent listed against valbenazine-tosylate.

Drugs covered by this patent

Patent Metadata

Patent number
EP2081929B1
Jurisdiction
EP
Classification
—
Expires
2013-01-09
Drug substance claim
No
Drug product claim
No
Assignee
Neurocrine Biosciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.